Researchers have uncovered a gene signature that may help predict clinical outcomes in certain types of breast cancer. They report that this gene signature -- which is associated with the transforming growth factor-beta (TGF-²) signaling pathway -- correlates with reduced relapse-free survival in patients with breast cancer, especially in those with estrogen receptor (ER) positive tumors.
Full article >>
Sunday, May 24, 2009
Gene Signature Helps Predict Breast Cancer Prognosis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment